Objective: This study aimed to assess trends and factors affecting inpatient hospital costs and length of stay (LOS) in surgical treatment of pelvic organ prolapse in the United States.
P elvic organ prolapse (POP) is present in 25% to 65% of postmenopausal women and one of the most common surgical indications. 1, 2 Pelvic organ prolapse procedures performed in inpatient settings account for two thirds (71%, $714 million) of costs related to POP treatment. 3, 4 Length of stay (LOS) is an outcome frequently evaluated as one of the top factors influencing hospital costs during inpatient stay. 5 Although economic analyses have been performed comparing different POP procedures, these studies did not address the factors increasing inpatient costs and LOS. [6] [7] [8] [9] Little is known regarding specific patient and hospital characteristics contributing to increased costs and LOS. This gap in knowledge limits our insight in proactively managing cost containment.
The American Urogynecologic Society Research Summit recommended to conduct relevant economic assessments, including the surgical care costs. 10 Current health care environment mandates the highest quality while minimizing cost of care. The Department of Health and Human Services has identified that improving quality while reducing the costs is a top priority for the next several years. 11 This will not be possible in surgical specialties unless surgeons analyze expenditures and identify the factors that increase the health care costs related to common surgical procedures.
We tested the hypothesis that patient and hospital characteristics are associated with inpatient costs and LOS during POP surgical treatment. Our objectives were as follows: (1) to assess whether and to what extent patient and hospital characteristics are associated with inpatient costs and LOS and (2) to evaluate the 2001-2011 trends in inpatient costs and LOS.
METHODS
This is a retrospective cross-sectional study using the 2011 National Inpatient Sample (NIS) database of the Healthcare Cost and Utilization Project (HCUP), sponsored by the Agency for Healthcare Research and Quality (AHRQ). In addition, we used the 2001-2011 NIS data for longitudinal trend analysis. This study was exempt from Case Western Reserve University Institutional Board Review because only unidentified publicly available data were analyzed.
The NIS is a database of hospital inpatient stays frequently used to identify, track, and analyze national trends in health care use, access, charges, quality, and outcomes. The NIS is the largest all-payer inpatient care database that is publicly available in the United States. It consists of inpatient stay records from all nonfederal, short-term, general, and other specialty hospitals, excluding hospital units of institutions, Veterans hospitals, other federal facilities (Department of Defense and Indian Health Service), and short-term rehabilitation hospitals. The NIS file for 2011 includes 8,023,590 hospital stays from 1049 nonfederal community hospitals in 46 states, representing approximately 20% of all hospital stays and 97% of the US population. The design and sampling techniques used in the NIS have been previously described. 12 Validity and reliability of the NIS have been studied extensively. 13 The primary dependent variables were mean cost per admission and LOS. Length of stay was the number of days from admission to discharge. We used the HCUP Cost-to-Charge Ratio Files to convert hospital total charges to an estimated total cost reflecting specific amounts that hospitals received in payments. These files contained hospital-specific cost-to-charge ratios based on allpayer inpatient costs obtained from the hospital accounting reports collected by the Centers for Medicare and Medicaid Services. 14 We tested the hypothesis that patient and hospital characteristics were associated with the inpatient costs and LOS during inpatient POP surgical treatment. The patient-level characteristics were age, race, comorbidities, community-level median household income, and insurance status. The NIS contains 6 race categories: Caucasian, African American, Hispanic, Asian/Pacific Islander, other, and unknown. We collapsed Asian/Pacific Islander and unknown into the "other" category because of low counts. Insurance was categorized based on the primary payer: Medicare, Medicaid, private insurance, self-pay or uninsured, and other. Communitylevel median household income provides a quartile classification of the estimated median household income of residents in the patient's zip code. We used secondary ICD-9 diagnosis codes to measure 29 different comorbidities, based on algorithms developed by AHRQ. 15 Agency for Healthcare Research and Quality comorbidities include a comprehensive list of illnesses that allows the evaluation of individual medical conditions and their independent effects on outcomes. Two of these comorbidities from the analysis were subsequently dropped-acquired immune deficiency syndrome and peptic ulcer disease-because very few (≤10) patients had these conditions.
Hospital-level characteristics included geographic region, bed size, location (urban and rural), teaching status (teaching and nonteaching), hospital ownership structure (public, private nonprofit, private for profit), and hospital volume of prolapse procedures. Hospital region is based on the 4 regions defined by the US Census Bureau: Northeast, South, Midwestern, and West. Hospital bed size was classified as small, medium, or large, based on an algorithm developed by HCUP. Bed size cutoff was different and specific to the hospital's region, location, and teaching status. For example, an urban teaching hospital was considered large with +325 beds at West, +375 at Midwest, +425 at Northeast, and +450 at South. Hospital volume was measured as the number of hospital stays involving prolapse procedures for each hospital in 2011. We categorized hospital volume into 4 categories with cutoff points based on quartiles. Surgeon volume was not included in our analysis because this measure was removed from the NIS because of concerns with reliability. We calculated trends in the annual mean total cost per admission and LOS for POP surgeries from 2001 to 2011. For trend analysis, costs were adjusted for inflation using real gross domestic product in chained 2011 dollars.
All analyses were performed using SAS version 9.3 for Unix. We calculated descriptive statistics for all variables in the study. The complex sample design of the study was accounted for using the appropriate procedures in SAS (SURVEYFREQ and SURVEYMEANS). For all descriptive analyses, we applied the discharge weights in the NIS to calculate national estimates. We calculated the mean unadjusted costs and LOS with 95% confidence intervals (CIs) for each variable, the association of each variable on cost and on LOS using F tests. Because of a large sample in the NIS database, we used a P value threshold of 0.001 and at least 20% change for a statistical test of association to be considered significant in the evaluation between comorbidities and LOS or cost. For multivariable analysis, costs and LOS were log transformed and fit to a linear model with a general estimating equations approach and exchangeable correlation structure to account for clustering by hospital. 16 By exponentiation of the parameter estimates in the regression model, we were able to calculate the proportional change and 95% CI for each study variable. The proportional change represents the effect associated with each variable on increasing (or decreasing) the continuous outcome (LOS or cost). The interpretation of proportional change is similar to that of a relative risk but for continuous outcomes rather than binary. Both models contained all of the independent study variables mentioned earlier including individual comorbidities. We also fit a null random-effects model to determine the intraclass correlation coefficient. 17 Table 1 depicts baseline patient and hospital characteristics. The mean age of the subjects was 59.0 years, with the majority being Caucasian (68.5%) and privately insured (53.0%) women. More than 60% of the population had at least 1 comorbid condition. The frequencies of specific medical comorbidities are noted in Figure 1 . More than 80% of all inpatient admissions occurred in urban teaching and nonteaching hospitals. Large bed size and private nonprofit hospitals had the majority of all inpatient admissions. The inpatient mortality rate was 4.29 per 10,000 (95% Table 2 shows the unadjusted mean LOS and mean total costs for each admission by patient and hospital characteristics. With respect to age, women 80 years and older had the longest LOS (2.13 days, P < 0.001). With respect to race, African American women had longest LOS (2.61 days, P = 0.023). With respect to insurance status, uninsured women had longest LOS (3.19 days, P < 0.001). There was a dose-response relationship between higher comorbidity count and increased LOS and hospital costs. Women who had 3 or more comorbidities had longest LOS (2.40 days) and highest inpatient hospital costs per admission ($10,294) than women with no comorbidities (LOS, 1.61 days; costs, $8642; all P values <0.001). Length of stay was shortest in urban nonteaching hospitals, small hospitals as measured by bed size, and hospitals with a highest (>75 percentile) volume of POP surgeries. Inpatient surgical treatment was most costly in the Western region hospitals and in publicly owned hospitals.
RESULTS
The intraclass correlation coefficient of patients within hospitals was 0.19 for LOS and 0.48 for average total cost, meaning that 19% and 48% of the variation in LOS and total cost, respectively, can be explained at the hospital level. There was only slight variance in cost by different types of surgical procedures. Table 3 demonstrates multivariable analyses of all patient and hospital characteristics associated with increased costs or prolonged hospitalization. When controlling for all variables, some patient characteristics were associated with longer LOS. African Americans had a 9% longer LOS compared with Caucasians (proportional change, 1.09; 95% CI, 1.05-1.13). In addition, compared with women with private insurance, Medicaid patients had a 7% (1.07; 95% CI, 1.04-1.10) and the uninsured had a 15% (1.15; 96% CI, 1.01-1.30) longer LOS. Select medical comorbidities associated with at least 20% higher mean costs (P < 0.001) controlling for all other variables included pulmonary circulation disorders at 1.37 (95% CI, 1.20-1.58; 37% higher costs compared with those without this disorder), metastatic cancer at 1.51 (95% CI, 1.28-1.77), coagulopathy at 1.26 (95% CI, 1.12-1.41), weight loss at 1.83 (95% CI, 1.45-2.32), and electrolyte/fluid imbalance at 1.36 (95% CI, 1.29-1.43). Comorbidities associated with at least 20% longer LOS (P < 0.001) controlling for all other variables were congestive heart failure at 1.25 (95 % CI, 1.14-1.36) (25% longer LOS compared with those without heart failure), pulmonary circulation disorders at 1.52 (95% CI, 1.25-1.85), metastatic cancer at 1.81 (95% CI,1.42-2.32), coagulopathy at 1.37 (95% CI,1.22-1.54), weight loss at 3.04 (95% CI, 2.41-3.84), electrolyte/ fluid disorders at 1.76 (95% CI, 1.66-1.88), blood loss anemia at 1.21 (95% CI, 1.12-1.31), and deficiency anemia at 1.21 (95% CI,1.17-1.26). 
DISCUSSION
This study revealed patient and hospital characteristics that are associated with increased inpatient costs and LOS in surgical POP treatment. Medical comorbidities (preexisting conditions or surgical complications) including fluid/electrolyte imbalance, coagulopathy, pulmonary circulation disorders, weight loss, and metastatic cancer are associated with both 20% increased costs and prolonged LOS. Congestive heart failure, blood loss, and deficiency anemia are associated with 20% increase in LOS. Age of 80 years or older, African American race, uninsured status, lower income, and lower surgical volume hospitals (≤75%) are risk factors associated with increased LOS. The cost of inpatient prolapse procedures is higher in public hospitals after multivariable adjustment. In 2001-2011, the mean total cost per admission significantly increased despite decreasing LOS.
Findings from this report add to the literature regarding the economics of inpatient surgical POP treatment focusing on risk factors associated with increased inpatient hospital costs and prolonged hospitalization. Data as these are especially important because physicians and hospitals begin to receive their payments linked to bundled as opposed fee-for-service payment models. 11 Pelvic surgeons, hospitals, and health care policy makers are the 3 key players to deliver high-quality surgical care for women with prolapse and to contain the costs. The knowledge about what leads to increased costs will allow these players to plan accordingly for necessary steps and resources. Although our study established the associations but not causality, it suggests that pelvic surgeons have presurgical attentiveness and consider careful preoperative planning. Patients with risk factors (age ≥ 80 years, African American race, uninsured status, lower income, and certain medical comorbidities) may have prolonged hospitalization or increased costs (or both) during surgical treatment. Based on previous reports that high-volume hospitals and surgeons have fewer postoperative complications and lower mortality rates along with our findings showing that highest surgical volume hospitals had the shortest LOS, we suggest that the hospitals develop high surgical volume programs or centers of excellence to treat women with pelvic floor disorders. 18, 19 Furthermore, the hospitals should evaluate the factors increasing costs of inpatient POP repairs based on the ownership as well as beyond patient and hospital characteristics. Finally, the knowledge about modifiable and nonmodifiable factors leading to longer hospitalization and higher costs is necessary to make an appropriate health care recourses allocation for vulnerable population subgroups that would require higher expenditures and prolonged hospitalization.
The literature indicates contradictory results on comorbidities and surgical outcomes in women with prolapse. 20, 21 These differences may be attributable to the use of a comorbidity index This study has some limitations inherent to the use of administrative databases and the ICD-9-CM procedure codes. However, HCUP analysis has concluded that the NIS provides reliable national estimates of average LOS and costs. To minimize a bias related to better hospital accounting, our findings are based on the cost-to-charge ratio analysis. This ratio provides a better estimate of the actual cost burden an inpatient stay compared with charges. The cross-sectional design of our study cannot evaluate the causality of increased inpatient costs or prolonged hospitalization. Although our report reveals inpatient increasing costs despite decreasing LOS over time, our study design is not able to explain why this occurs. This data set did not allow us to analyze the cost and the length of hospitalization related to outpatient surgeries or any specific prolapse procedure. We were not able to assess the impact of complex surgical procedures on primary outcomes. As the number of outpatient POP surgical procedures significantly increased in recent years, the evaluation of factors affecting the costs and LOS in outpatient surgery is necessary. Despite our inability to evaluate outpatient POP surgeries, this analysis is important because inpatient POP surgeries account for a significant proportion of costs related to POP treatment. 4 The study strengths include evaluation of the trends and factors increasing inpatient costs and LOS in prolapse surgical treatment. This study reports on costs reflecting true hospital payments rather than hospital charges. The large sample size and the NIS representativeness across all insurer types and demographics of the United States are unmatched by any other database. The data from this study are necessary for physicians, hospital administrations, and health policy agencies to develop strategies and initiatives to decrease the costs and the length of hospitalization during inpatient stay. This is especially important because our analysis revealed rising cost for inpatient prolapse surgical procedures despite decreasing LOS between 2001 and 2011. Some modifiable factors such as preoperative planning, perioperative management of medical conditions (preexisting or surgical complications), and high-volume surgical programs may lead to decreased costs and LOS. In contrast, the knowledge about nonmodifiable factors that lead to increased expenditures and prolonged hospitalization will allow the physicians and hospitals to advocate and plan for necessary health care recourse allocation.
